Lee, C. K., Davies, L., Wu, Y. L., Mitsudomi, T., Inoue, A., Rosell, R., . . . Yang, J. C. H. (2018). Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
Chicago Style CitationLee, Chee Khoon, et al. Gefitinib or Erlotinib Vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival. 2018.
MLA引文Lee, Chee Khoon, et al. Gefitinib or Erlotinib Vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival. 2018.
警告：這些引文格式不一定是100％准確.